Globus Medical India Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
as on 10-01-2025
- Paid Up Capital ₹ 48.93 Cr
as on 10-01-2025
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Dec 2023
- Revenue 33.71%
(FY 2022)
- Profit 139.34%
(FY 2022)
- Ebitda -26.28%
(FY 2022)
- Net Worth 0.65%
(FY 2022)
- Total Assets 0.83%
(FY 2022)
About Globus Medical India
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 December 2023. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 48.93 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Globus Medical India Private Limited India is Pooja Dixit as COMPANY SECRETARY. Showkatali Nizamudeen, Balan Sairam, and David Paul serve as directors at the Company.
- CIN/LLPIN
U51507TN2006PTC058707
- Company No.
058707
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 2006
- Date of AGM
29 Jun 2024
- Date of Balance Sheet
31 Dec 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Globus Medical India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pooja Dixit  | Company Secretary | 10-Jun-2019 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Showkatali Nizamudeen | Director | 06-Sep-2022 | Current |
| Balan Sairam | Director | 06-Sep-2022 | Current |
| David Paul | Director | 31-Jan-2006 | Current |
Financial Performance of Globus Medical India.
Globus Medical India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 33.71% increase. The company also saw a substantial improvement in profitability, with a 139.34% increase in profit. The company's net worth moved up by a moderate rise of 0.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Globus Medical India?
In 2022, Globus Medical India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Globus Medical India?
Globus Medical India has a workforce of 98 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Globus Medical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Globus Medical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
